|
Volumn 37, Issue 5, 2005, Pages 2069-2071
|
The cost-effectiveness of Basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OPTORAL;
TACROLIMUS;
UNCLASSIFIED DRUG;
AGED;
ALTERNATIVE MEDICINE;
ARTICLE;
BAYES THEOREM;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
COHORT ANALYSIS;
CONFIDENCE INTERVAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
HEALTH PROGRAM;
HUMAN;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MEDICAL DECISION MAKING;
MONTE CARLO METHOD;
PARAMETER;
PRIORITY JOURNAL;
PROBABILITY;
QUANTITATIVE ANALYSIS;
SIMULATION;
STATISTICAL MODEL;
TREATMENT OUTCOME;
AGE FACTORS;
AGED;
ANTIBODIES, MONOCLONAL;
BAYES THEOREM;
COMPUTER SIMULATION;
COST-BENEFIT ANALYSIS;
DIURESIS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MARKOV CHAINS;
MONTE CARLO METHOD;
RECOMBINANT FUSION PROTEINS;
SPAIN;
TREATMENT OUTCOME;
UNCERTAINTY;
|
EID: 21844452150
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.03.008 Document Type: Article |
Times cited : (9)
|
References (6)
|